NM_000448.3:c.1303A>G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 13P and 1B. PM1PM2PP2PP5_Very_StrongBP4
The NM_000448.3(RAG1):c.1303A>G(p.Met435Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000448.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- Omenn syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Genomics England PanelApp, Ambry Genetics
- recombinase activating gene 1 deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positiveInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- combined immunodeficiency due to partial RAG1 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAG1 | NM_000448.3 | c.1303A>G | p.Met435Val | missense_variant | Exon 2 of 2 | ENST00000299440.6 | NP_000439.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152238Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250804 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461888Hom.: 0 Cov.: 36 AF XY: 0.0000509 AC XY: 37AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
- -
Published functional studies demonstrate that M435V only has 23.6% of WT VDJ recombination activity Lee 2014); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25976673, 17890453, 20956421, 24290284, 19178939, 22039266, 11133745, 31058115, 31388879, 32311393, 30877075, 33193364) -
- -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C1835931:Combined immunodeficiency due to partial RAG1 deficiency;C2673536:Combined immunodeficiency with skin granulomas;C2700553:Histiocytic medullary reticulosis Pathogenic:1
- -
Severe combined immunodeficiency disease Pathogenic:1
Variant summary: RAG1 c.1303A>G (p.Met435Val) results in a conservative amino acid change located in the RAG nonamer-binding domain (IPR023336) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be tolerated. The variant allele was found at a frequency of 2.8e-05 in 250804 control chromosomes. c.1303A>G has been observed in multiple individuals affected with Severe Combined Immunodeficiency Syndrome/Omenn Syndrome (example: Villa_2001, Haq_2007, Matangkasombut_2008, Sheehan_2009, Dobbs_ 2017). These data indicate that the variant is associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 10%-<30% of normal VDJ recombination activity (example: Lee_2014). The following publications have been ascertained in the context of this evaluation (PMID: 28769923, 17572155, 24290284, 17890453, 11213808, 19178939, 11133745). ClinVar contains an entry for this variant (Variation ID: 68680). Based on the evidence outlined above, the variant was classified as pathogenic. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Pathogenic:1
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 435 of the RAG1 protein (p.Met435Val). This variant is present in population databases (rs141524540, gnomAD 0.006%). This missense change has been observed in individual(s) with Omenn syndrome (PMID: 11133745, 17890453, 24290284, 28769923). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 68680). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt RAG1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects RAG1 function (PMID: 24290284). For these reasons, this variant has been classified as Pathogenic. -
RAG1-related disorder Pathogenic:1
The RAG1 c.1303A>G variant is predicted to result in the amino acid substitution p.Met435Val. This variant was reported in individuals with Omenn syndrome (see for example Villa et al 2001. PubMed ID: 11133745, Lee et al 2013. PubMed ID: 24290284; Dobbs et al 2017. PubMed ID: 28769923). This variant is reported in 0.0053% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Combined immunodeficiency due to partial RAG1 deficiency Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at